Praetura Ventures and NPIF II Invest £1.4M in Northern Tech and Life Sciences Startups via PraeSeed Programme
Seven startups from the North of England have secured a share of £1.4M through PraeSeed, a six-week investment programme for early-stage businesses, launched by Praetura Ventures and the Northern Powerhouse Investment Fund II (NPIF II). The initiative aims to identify high-potential startups and provide them with funding and guidance to scale. Each selected business will receive £200K in funding as part of PraeSeed's commitment to fostering innovation in the North of England.
The inaugural cohort of 12 businesses underwent a structured programme, including workshops on scaling, go-to-market strategies, financial modelling, and fundraising. From this group, seven businesses across various sectors were chosen for investment. These include:
- CCI Photonics (Lancaster): A spinout developing InfectiScan™, a test to help clinicians identify infections and reduce antimicrobial resistance.
- Robotiz3d (SciTech Daresbury): A University of Liverpool spinout creating autonomous vehicles and specialised cameras to detect and repair road damage.
- North AI (Manchester): Using AI to assist media and entertainment companies with commissioning and licensing decisions.
- Aquaint (Manchester): Developer of a compliance and workflow app for hospitality and food service industries.
- ScrubMarine (Whitehaven): Innovators of a submersible vehicle to clean marine vessels affected by biofouling.
- BidScript (Warrington): Machine learning-powered software to streamline the bid management process for organisations.
- WAC: A B2C app for hourly workers to track and resolve discrepancies in wages.
The cohort also highlights significant strides in diversity, with 29% led by female founders and 86% co-founded by individuals from BAME backgrounds.
Jessica Jackson, Praetura Ventures' investment manager and PraeSeed lead, praised the quality of applicants, stating:
"The North is alive with innovation. These seven businesses displayed the tenacity, talent, and willingness to learn required to scale successfully. We’re also proud of the diversity across our cohort, with funding enabling these entrepreneurs to achieve significant milestones."
The £660M NPIF II, which supports PraeSeed, aims to enhance access to early-stage finance for businesses across the North, fostering sustainable growth and breaking down barriers to investment. PraeSeed’s next cohort will launch in March 2025, with details available through Praetura Ventures' social platforms.
Newcells raises further £1.2M for lab models that speed up drug development
Newcells Biotech, a Newcastle-based company specialising in 3D tissue models for drug development, has raised £1.2M in funding from existing investors Mercia Ventures, Northstar Ventures, and North East Finance. The investment will help Newcells expand its customer base, forge new partnerships, and enhance its offering, which provides pharmaceutical companies with more effective alternatives to animal testing. Newcells' 3D models, which replicate human tissues such as the retina, kidney, and lungs, allow for better predictions of how drugs will behave in the human body, speeding up the development process and reducing costs.
Cerve secures £3.5M Seed funding to revolutionise the global food supply chain
Cerve, a provider of infrastructure and API solutions for the digitised global food system, has successfully closed a £3.5M seed funding round. The round was led by SuperSeed, a B2B SaaS-focused VC, with additional participation from Zenith, Ponderosa, and The First Thirty. Cerve’s mission is to accelerate the digitisation of the global food supply chain through standardised API tools, enabling organisations to build custom applications and automations that drive profitability, reduce food waste, and improve food security.
Cerve’s technology addresses significant inefficiencies in the global food system, which relies heavily on outdated, manual data-sharing methods such as emails and spreadsheets. These methods hinder efficiency, limit visibility, and create missed opportunities. Over one-third of all food produced globally is wasted, much of it due to a lack of traceability in supply chains. Cerve’s infrastructure overcomes these challenges by enabling seamless data integration, fostering a more connected and sustainable food system that can scale to meet global needs.
The company’s platform is already in use by over 2,000 organisations across the UK and Europe, including retailers, wholesalers, manufacturers, and producers. With the new funding, Cerve plans to expand commercially in the UK, Europe, and North America, while strengthening its R&D capabilities and building out its engineering, product, and technical support teams. Founded by Dan Mazig, a serial entrepreneur with expertise in data infrastructure, and David Walker, former senior executive at Barclays, Dyson, and Sky, Cerve aims to revolutionise the food industry by addressing the most pressing global challenges, such as food waste and security.
Netacea raises further £4M to step up battle against the bots
Digital bank Zopa raises £68M to accelerate growth ahead of 2025 current account launch
Embeddable secures £4.94M seed funding to help development teams build bespoke, fast-loading customer-facing analytics
Embeddable, a cutting-edge developer tool for embedding interactive analytics into software applications, has closed an oversubscribed £4.94M seed funding round led by OpenOcean, with participation from Four Rivers, TechStars, and investors behind MySQL, MariaDB, and Docker. Despite its lean 14-member team, Embeddable has signed contracts with 36 companies ranging from startups to billion-dollar enterprises. Its Private Beta, launched in December 2023, has attracted over 800 applications and generates over €100,000 in new contracts monthly.
The platform addresses challenges with traditional embedded analytics tools—slow performance, limited customisation, and high engineering demands—through a headless architecture. The company plans to strengthen its team and developer community, fostering collaborative innovation with a library of user-contributed templates akin to platforms like Notion.
CEO Tom Gardiner compared Embeddable’s mission to Stripe’s transformation of online payments: "Embedding analytics is now as essential as adding payments or chat features. We’re empowering teams to deliver fast, interactive data experiences at scale while creating a collaborative community."
In other investment news
Clyde Hydrogen achieves major technical milestone in decoupled hydrogen production and launches £5M funding round
In other international investment news
FibreCoat, world leader in materials technology, secures close to €20M from NewSpace Capital and other investors in Series B raise
FibreCoat, a materials technology innovator, has raised nearly €20M in a Series B funding round co-led by NewSpace Capital and Goose Capital, with participation from several notable investors, including Nova Saint-Gobain, 212 NexT, and Otto Krahn New Business. The funding will accelerate FibreCoat’s expansion as it positions itself to become the world’s largest manufacturer of coated fibers, with a focus on scaling production and advancing coatings tailored for the space and defense sectors.
Founded in Germany in 2020, FibreCoat’s breakthrough technology combines metals and plastics onto fibers during the spinning process, delivering lightweight, cost-effective, and high-performance materials. These products are critical for industries requiring strength, conductivity, and recyclability, particularly in the face of extreme conditions like those encountered in space or military applications. The company’s innovations address growing demand in the $9.3B EMI shielding market and align with projections for the global space ecosystem to reach $1.8T by 2035.
Evidently secures $15M Series A to transform healthcare workflows
Evidently, an AI platform revolutionising healthcare, has raised $15M in Series A funding led by DN Capital, with support from FRAMEWORK, Clear Ventures, Fellows Fund, and others. The funding will scale its flagship EvidentlyOne platform and develop new solutions for population health and clinical research. Evidently simplifies fragmented healthcare data by acting as an AI resident, delivering actionable insights and decision support. The platform is already making a measurable impact, reducing chart prep time by 90%, improving Case Mix Index accuracy, and helping ACOs increase their Risk Adjustment Factor.
CEO Feng Niu, a seasoned AI entrepreneur, emphasised the platform’s mission to enhance care while reducing clinician burnout. "By automating repetitive cognitive tasks, we’re enabling providers to focus on delivering exceptional care," he said. The company is already deployed at leading health systems, including the University of Iowa, demonstrating its scalability and value.
Investors praised Evidently’s transformative potential. Gulsah Wilke of DN Capital noted its ability to solve inefficiencies and improve outcomes, while Peter Misek of FRAMEWORK highlighted its human-first AI approach. With this funding, Evidently is positioned to expand its reach and redefine how healthcare providers leverage AI.